The Sorry State of Indian Surrogates
By Gina Maranto, <i>Biopolitical Times</i> guest contributor
| 08. 06. 2013
The surrogacy industry in India is both booming and changing. A new 168-page report from the Centre for Social Research, a women’s advocacy group based in New Delhi, finds that the industry appears to be shifting from towns like Anand and Amritsar to the megacities Mumbai and New Delhi, which are more easily accessible to international travelers and have higher quality health care facilities. Surrogate Motherhood: Ethical or Commercial documents a range of disturbing conditions: Although the government has guidelines for assisted reproduction clinics, regulation continues to be spotty and current law affords scant protection to the poor, largely uneducated women who are being drafted to serve as incubators, or to the resulting children handed over to primarily foreign clients.
Foreign scholars and journalists have probed the Indian surrogacy business for some years. Within the country, groups like the Sama Resource Group for Women and Health have drawn attention to the broader practices of ART clinics, as in their 2008 publication Cheap and Best, which puts the industry in the context of global medical tourism and examines the...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...